Valeritas designs, manufactures and distributes insulin delivery devices for diabetic patients. Valeritas was founded in 2006. Valeritas' headquarters is located in Bridgewater, New Jersey, USA 08807.
Valeritas' President & CEO, John Timberlake, curr... Valeritas's President & CEO, John Timberlake, currently has an approval
rating of 78%. Valeritas's primary competitors are Novo Nordisk, AstraZeneca & Sanofi.
There have been no acquisitions found related to Valeritas
Recent investment data cannot be found related to Valeritas